DouglasRonaldLowyMD

Dermatology • Bethesda, MD

Physician

Join to view full profile

Are you Dr. Lowy?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 21 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
31 Center Dr
Bldg 31
Bethesda, MD 20892
Phone+1 301-827-5699

Fax+1 301-435-2396
Is this information wrong?

Summary

Dr. Douglas Lowy, MD is a board certified dermatologist in Bethesda, Maryland. He is currently licensed to practice medicine in New York.

Education & Training

Yale-New Haven Medical CenterResidency, Dermatology, 1973 - 1975
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1969 - 1970
New York University School of MedicineClass of 1968

Certifications & Licensure

NY State Medical License 1974 - 2024
American Board of Dermatology Dermatology
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix(®).
Kemp, T. J., Safaeian, M., Hildesheim, A., Pan, Y., Penrose, K. J., Porras, C., Schiller, J. T., Lowy, D. R., Herrero, R., Pinto, L. A.> ;Vaccine. 2012 Dec 17
Murine skin and vaginal mucosa are similarly susceptible to infection by pseudovirions of different papillomavirus classifications and species.
Handisurya, A., Day, P. M., Thompson, C. D., Buck, C. B., Kwak, K., Roden, R. B., Lowy, D. R., Schiller, J. T.> ;Virology. 2012 Nov 25
Functional Interaction of Tumor Suppressor DLC1 and Caveolin-1 in Cancer Cells.
Schetter, A. J., Papageorge, A., Robles, A. I., Lowy, D. R., Braverman, R., Vass, W. C., Liu, X., Qian, X., Du, X.> ;Cancer Res. 2012 Sep 1
A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibi...
Thompson, C. D., Lowy, D. R., Schiller, J. T., Day, P. M., Kines, R. C., Pang, Y. Y.> ;Clin Vaccine Immunol. 2012 Jul
Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA.
Hryniewicz, A., Graham, B. S., Buck, C. B., Miller, C. J., Fenizia, C., Lowy, D. R., Brocca-Cofano, E., Kutsyna, G., Franchini, G., Roberts, J. N., Schiller, J. T., Be...> ;J Immunol. 2012 Jan 15
Reducing HPV-associated cancer globally.
Lowy, D. R., Schiller, J. T.> ;Cancer Prev Res (Phila). 2012 Jan
Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK).
Papageorge, A. G., Lowy, D. R., Li, G., Vass, W. C., Qian, X., Du, X.> ;Proc Natl Acad Sci USA. 2011 Oct 11
Proof-of-principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine.
, Kreimer, A. R., Hildesheim, A., Rodriguez, A. C., Porras, C., Solomon, D., Lowy, D. R., Schussler, J., Schiller, J. T., Schiffman, M., Sherman, M. E., González, P., ...> ;J Natl Cancer Inst. 2011 Oct 5
Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica.
, Kreimer, A. R., Hildesheim, A., Rodríguez, A. C., Porras, C., Solomon, D., Lowy, D. R., Schussler, J., Schiller, J. T., Schiffman, M., Sherman, M. E., González, P., ...> ;Cancer Discov. 2011 Oct
Effect of Pap smear collection and carrageenan on cervicovaginal human papillomavirus-16 infection in a rhesus macaque model.
Lowy, D. R., Katki, H. A., Roberts, J. N., Schiller, J. T., Kines, R. C.> ;J Natl Cancer Inst. 2011 May 4
In vivo longitudinal imaging of experimental human papillomavirus infection in mice with a multicolor fluorescence mini-endoscopy system.
Hasegawa, A., Lowy, D. R., Kobayashi, H., Roberts, J. N., Schiller, J. T., Mitsunaga, M., Kosaka, N., Choyke, P. L., Kines, R. C., Ishihara, Y.> ;Cancer Prev Res (Phila). 2011 May
HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection.
Hildesheim, A., Porras, C., Lowy, D. R., Schiller, J. T., Dauner, J. G., Pinto, L. A., Safaeian, M., Herrero, R., Kemp, T. J., Pan, Y.> ;Vaccine. 2011 Mar 3
In vivo mechanisms of vaccine-induced protection against HPV infection.
Thompson, C. D., Lowy, D. R., Schiller, J. T., Day, P. M., Kines, R. C., Roden, R. B., Jagu, S.> ;Cell Host Microbe. 2010 Sep 16
Vaccines to prevent infections by oncoviruses.
Lowy, D. R., Schiller, J. T.> ;Annu Rev Microbiol. 2010
The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding.
Thompson, C. D., Lowy, D. R., Schiller, J. T., Day, P. M., Kines, R. C.> ;Proc Natl Acad Sci USA. 2009 Nov 19
The Tensin-3 protein, including its SH2 domain, is phosphorylated by Src and contributes to tumorigenesis and metastasis.
Papageorge, A., Lowy, D. R., Tosato, G., Li, G., Hunter, K., Asnaghi, L., Steinbach, P. J., Walker, R. C., Vass, W. C., Qian, X.> ;Cancer Cell. 2009 Sep 08
Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines.
Karanam, B., Lowy, D. R., Schiller, J. T., Gambhira, R., Chaganti, R. J., Roden, R. B., Jagu, S., Chivukula, S. V.> ;J Natl Cancer Inst. 2009 May 28
p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities.
Der, C. J., Vigil, D., Lowy, D. R., Guan, M., Popescu, N. C., Yang, X. Y.> ;Oncogene. 2009 Jan 20
Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus.
Lowy, D. R., Roberts, J. N., Schiller, J. T., Johnson, K. M., Day, P. M., Kines, R. C.> ;J Virol. 2008 Dec 17
Gene expression patterns induced by HPV-16 L1 virus-like particles in leukocytes from vaccine recipients.
García-Piñeres, A. J., Hildesheim, A., Fullmer, B., Harro, C., Lowy, D. R., Yang, J., Pinto, L. A., Dodd, L., Lempicki, R. A., Kemp, T. J.> ;J Immunol. 2009 Jan 22
Getting stronger: the relationship between a newly identified virus and Merkel cell carcinoma.
Buck, C. B., Lowy, D. R.> ;J Invest Dermatol. 2008 Dec 17
HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women.
Chaturvedi, A. K., Lowy, D. R., Gillison, M. L.> ;Cancer. 2008 Nov 05
Human papillomavirus infection and the primary and secondary prevention of cervical cancer.
Hildesheim, A., Solomon, D., Lowy, D. R., Schiller, J. T., Schiffman, M.> ;Cancer. 2008 Sep 19
Arrangement of L2 within the papillomavirus capsid.
Steven, A. C., Trus, B. L., Buck, C. B., Thompson, C. D., Lowy, D. R., Schiller, J. T., Cheng, N.> ;J Virol. 2008 Jun
Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies.
Lowy, D. R., Schiller, J. T., Day, P. M., Gambhira, R., Roden, R. B.> ;J Virol. 2008 May
Join now to see all

Press Mentions

10-Year Anniversary Celebration of the DOD’s Only Center of Excellence for Cancer Care and Research, John P. Murtha Cancer CenterDecember 2nd, 2022
Four Multinational, Interdisciplinary Teams Selected to Address Major Challenges in CancerJune 16th, 2022
Increased Access to Care and Reduced Treatment Delays Lead Priorities as Radiation Oncologists Meet with Members of CongressMay 17th, 2022
Join now to see all